Allorion Therapeutics
Founded 2020 · 31 employees on LinkedIn · 7 known investors
Allorion Therapeutics is a biotech company developing next-generation targeted small-molecule drugs for human diseases, using data-driven discovery platforms and partnerships with pharmaceutical companies for commercialization.
Founders & leadership
Allorion Therapeutics was founded in 2020 by Fang Li.
FL
Fang LiinCo-Founder / Chief Scientific Officer
Investors · 7
Also in the syndicate · 5
3SBioElikon VentureLong River Investment (LRI)Octagon CapitalTF Capital
Funding
SEC filings, press & company announcements$50M disclosed across 1 of 2 rounds · 2023
- $50MSeries BMar 2023 · 3 sources
INCE Capital (lead), Qiming Venture Partners (lead), 3SBio, Elikon Venture, Long River Investment (LRI), Octagon Capital, TF Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Allorion Therapeutics do?
- Allorion Therapeutics is a biotech company developing next-generation targeted small-molecule drugs for human diseases, using data-driven discovery platforms and partnerships with pharmaceutical companies for commercialization.
- Who founded Allorion Therapeutics?
- Allorion Therapeutics was founded by Fang Li in 2020.
- Who are Allorion Therapeutics's investors?
- Allorion Therapeutics's investors include INCE Capital, Qiming Venture Partners.
- How much funding has Allorion Therapeutics raised?
- Allorion Therapeutics has disclosed $50M raised across 1 of its 2 known rounds.